After months of intense negotiations, China’s Alibaba Group said it has reached an agreement with Yahoo and Softbank that promises the e-commerce giant could receive up to $6 billion from an IPO or liquidation of its e-payment unit, Alipay.
By Matthew Goldstein
Top hedge fund managers are great at enriching themselves through savvy trades that presumably come from a keen insight into the markets and economic trends. But all too often these titans of Wall Street come up small when asked for their opinions on the pressing economic questions of the day.
Group buying sites Groupon and LivingSocial are both in the process of launching multi-billion dollar IPOs, but as Deal Journal reports, the companies are also “plowing full steam ahead with deal making.”
There appears to be a strong demand for this week’s biggest deal. Dunkin’ Brands, the provider of sweet treats and coffee raised $422.75 million after pricing its IPO at $19 per share, well above the range set by underwriters. This gives the parent of the Dunkin’ Donuts and Baskin Robbins chains a market value of just over $2.4 billion.
Billionaire hedge fund manager George Soros will be returning capital to outsiders and ending his nearly four-decade long career. In a letter to investors, Soros’ two sons cited tougher impending regulations on the hedge fund industry being the reason for returning the money. Soros said he will now only manage money for himself.
Shareholders of Hynix Semiconductor will take final bids for a controlling stake in the South Korean memory chipmaker, said a leading shareholder. The $2.3 billion stake sale is the third attempt by creditors-turned-shareholders to find a new owner for the company.
By Matthew Goldstein
Derivatives guru Janet Tavakoli is a long-time critic of the rating agencies and in particular the role the raters played in the subprime debt crisis. And she says given the shabby job the rating agencies did in giving the green light to the subprime debt boom, it’s odd to think of firms like Standards & Poor’s playing such a big role in the ongoing US debt ceiling negotiations.
For a self-described nerdy accountant who shuns attention, Express Scripts chief George Paz just thrust himself into the limelight, reports Lewis Krauskopf. The company’s planned buy of Medco Health Solutions met with swift opposition from consumer advocates and drug stores, signaling the beginning of what could be an ugly fight for antitrust approval.
Express Scripts will buy rival Medco Health Solutions for $29.1 billion in cash and stock to create a powerhouse in managing prescription drug benefits in the United States, the companies said on Thursday. The WSJ live blogged the companies’ conference call on the merger.